anti-CD19 CAR-T cell therapy / Shanghai Children's Medical Center 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
anti-CD19 CAR-T cell therapy / Shanghai Children's Medical Center
ChiCTR-ONC-16009889: A single center, prospective, clinic study of anti-CD19 chimeric antigen receptor T cells treating refractory and relapsed children B acute lymphoblastic leukemia

Not yet recruiting
N/A
20
 
CD19CART Cell Therapy
Shanghai Children's Medical Center affiliated to Shanghai Jiao Tong University School of Medicine; Shanghai Children's Medical Center affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Children's Medical Center affiliated to Shanghai Jiao Tong University School of Medicine
refractory and relapsed acute lymphoblastic leukemia
 
 

Download Options